Eklund, E.A.; Wiel, C.; Fagman, H.; Akyürek, L.M.; Raghavan, S.; Nyman, J.; Hallqvist, A.; Sayin, V.I.
KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer. Cancers 2022, 14, 2063.
https://doi.org/10.3390/cancers14092063
AMA Style
Eklund EA, Wiel C, Fagman H, Akyürek LM, Raghavan S, Nyman J, Hallqvist A, Sayin VI.
KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer. Cancers. 2022; 14(9):2063.
https://doi.org/10.3390/cancers14092063
Chicago/Turabian Style
Eklund, Ella A., Clotilde Wiel, Henrik Fagman, Levent M. Akyürek, Sukanya Raghavan, Jan Nyman, Andreas Hallqvist, and Volkan I. Sayin.
2022. "KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer" Cancers 14, no. 9: 2063.
https://doi.org/10.3390/cancers14092063
APA Style
Eklund, E. A., Wiel, C., Fagman, H., Akyürek, L. M., Raghavan, S., Nyman, J., Hallqvist, A., & Sayin, V. I.
(2022). KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer. Cancers, 14(9), 2063.
https://doi.org/10.3390/cancers14092063